Ginkgo biloba extract EGb 761®: From an ancient Asian plant to a modern european herbal medicinal product

Evidence and Rational Based Research on Chinese Drugs

Volumn 9783709104422, Issue , 2013, Pages 431-470

  Lang, Friedrich ^a   Hoerr, Robert ^a   Noeldner, Michael ^a   Koch, Egon ^a  

^a DR WILLMAR SCHWABE GMBH AND CO KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84888878706     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-7091-0442-2_11     Document Type: Chapter

References (177)

1. Abdel-Kader RM, Hauptmann S, Keil U, Scherping I, Leuner K, Eckert A, Mueller WE (2007) Stabilization of mitochondrial function by Ginkgo biloba extract (EGb 761). Pharmacol Res 56(6):493-502
2. Aisen PS, Andrieu S, Sampaio C, Carrillo M, Khatchaturian ZS, Dubois B, Feldman HH, Petersen RC, Siemers E, Doody RS, Hendrix SB, Grundman M, Schneider LS, Schindler RJ, Salmon E, Potter WZ, Thomas RG, Salmon D, Donohue M, Bednar MM, Touchon J, Vellas B (2011) Report of the task force on designing clinical trials in early (predementia) AD. Neurology 76:280-286
3. Aldridge WN, Street BW, Skilleter DN (1977) Oxidative phosphorylation. Halide-dependent and halide-independent effects of triorganotin and trioganolead compounds on mitochondrial functions. Biochem J 168:353-64
4. Arenz A, Klein M, Fiehe K, Gross J, Drewke C, Hemscheidt T, Leistner E (1996) Occurrence and biosynthesis of neurotoxic 4'-O-methylpyridoxine in Ginkgo biloba [Abstr. SL 20], 44th Annu. Congr. Med. Plant Res., Prague, CZ, 3.-7. 9. 1996, p 25
5. Arenz A, Klein M, Fiehe K, Gross J, Drewke C, Hemscheidt T, Eckhard L (1996b) Occurrence of neurotoxic 4'-O-methylpyridoxine in Ginkgo biloba leaves, Ginkgo medications and Japanese Ginkgo food. Planta Med 62(6):548-551
6. Auguet M, Clostre F, De Feudis FV (1986) Effects of antidepressants on receptor-activated and Ca2+-activated contractions of rabbit isolated aorta. Gen Pharmacol 17:607-610
7. Augustin S, Rimbach G, Augustin K, Schliebs R, Wolffram S, Cermak R (2009) Effect of a shortand long-treatment with Ginkgo biloba extract on amyloid precursor protein levels in a transgenic mouse model relevant to Alzheimer's disease. Arch Biochem Biophys 481:177-182
8. Ahlemeyer B, Krieglstein J (2003) Pharmacological studies supporting the therapeutic use of Ginkgo biloba extract for Alzheimer's disease. Pharmacopsychiatry 36(Suppl. 1):S8-S14
9. Barkats M, Venault P, Christen Y, Cohen-Salmon C (1995) Effect of long-term treatment with EGb 761® on age-dependent structural changes in the hippocampi of three inbred mouse strains. Life Sci 56:213-222
10. Barth SA, Inselmann G, Engemann R, Heidemann HT (1991) Influences of Ginkgo biloba on cyclosporin A induced lipid peroxidation in human liver microsomes comparison to vitamin E, glutathione and N-acetylcysteine. Biochem Pharmacol 41:1521-1526
11. Bastianetto S, Ramassamy C, Doré S, Christen Y, Poirier J, Quirion R (2000) The Ginkgo biloba extract (EGb 761®) protects hippocampal neurons against cell death induced by beta-amyloid. Eur J Neurosci 12:1882-90
12. Bennett DA, Wilson RS, Schneider JA, Evans DA, Beckett LA, Aggarwal NT, Barnes LL, Fox JH, Bach J (2002) Natural history of mild cognitive impairment in older persons. Neurology 59:198-205
13. Biber A, Koch E (1999) Bioavailability of ginkgolides and bilobalide from extracts of Ginkgo biloba using GC/MS. Planta Med 65:192-193
14. Biber A (2003) Pharmacokinetics of Ginkgo biloba extracts. Pharmacopsychiatry 36(Suppl. 1):S32-S37
15. Blecharz-Klin K, Piechal A, Joniec I, Pyrzanowska J, Widy-Tyszkiewicz E (2009) Pharmacological and biochemical effects of Ginkgo biloba extract on learning, memory consolidation and motor activity in old rats. Acta Neurobiol Exp 69:217-231
16. Blume J, Kieser M, Hölscher U (1996) Placebo-controlled double blind study on the efficacy of Ginkgo biloba special extract EGb 761® in maximum level trained patients with intermittent claudication (in German). Vasa 25:265-274
17. Blumenthal M, Busse WR, Goldberg A, Gruenwald J, Hall T, Riggins CW, Rister RS, Klein S (1998) The complete German commission E monographs therapeutic guide to herbal medicines developed by a special expert Committee of the German Federal Institute for Drugs and Medical Devices. Am. Bot. Counc., Austin, TX, USA
18. Boulie R, Munoz JF, Macovshi Panes O, Pacheco H (1988) Implication de la peroxidation lipidique dans l'intoxication par le triethyletain chez le rat. C R Seances Soc Biol Ses Fil 182:196-201
19. Braquet P (1987) The ginkgolides: potent platelet-activating factor antagonists' isolated from Ginkgo biloba L.: chemistry, pharmacology and clinical applications. Drugs Fut 12:643-699
20. Bulling B, Von Bary S (1991) The treatment of chronic peripheral arterial occlusion disease with physical exercise and Ginkgo biloba extract 761 (in German). Medwelt 42:702-708
21. Chandrasekaran K, Mehrabian Z, Spinnewyn B, Chinopoulos C, Drieu K, Fiskum G (2002) Bilobalide, a component of the Ginkgo biloba extract (EGb 761®), protects against neuronal death in global brain ischemia and in glutamate-induced excitotoxicity. Cell Mol Biol 48:663-669
22. Chatterjee SS (1985) Effect of Ginkgo biloba extract on cerebral metabolic processes. In: Agnoli A, Rapin JR, Scapagnini V, Weibrecht WV (eds) Effect of Ginkgo biloba extract on organic cerebral impairment. John Libbey Eurotext, London, pp 5-15
23. Chatterjee SS, Gabard BL (1981) Protective effect of an extract of Ginkgo biloba and other hydroxyl radical scavengers against hypoxia [Abstr. 866]. IUPHAR 8th Int. Congr. Pharmacol. Tokyo, JP 19.7.1981-24.7.1981, p 483
24. Chatterjee SS, Gabard BL (1982a) Studies on the mechanism of action of an extract of Ginkgo biloba, a drug used for treatment of ischemic vascular diseases [Abstr. 207]. Naunyn Schmiedeberg's Arch Pharmacol 321(Suppl):R52
25. Chatterjee SS, Gabard BL (1982b) Protection of doxorubicin toxicity by an extract of Ginkgo biloba [Abstr. 57]. Naunyn Schmiedeberg's Arch Pharmacol 319(Suppl):R15
26. Chatterjee SS, Gabard BL (1984) Effect of an extract of Ginkgo biloba on experimental neurotoxicities [Abstr. 327]. Naunyn Schmiedeberg's Arch Pharmacol 325(Suppl):R82
27. Chatterjee SS, Noeldner M (1989) Behavioural observations demonstrating influences of the extract of Ginkgo biloba (EGb 761®) on some specific central cholinergic systems [Abstr. 425]. Naunyn Schmiedeberg's Arch Pharmacol 339(Suppl):R107
28. Chatterjee SS, Cees J, Doelman A, Nöldner M, Biber A, Koch E (2005) Influence of the Ginkgo extract EGb 761® on rat liver cytochrome P450 and metabolism and excretion in rats and man. J Pharm Pharmacol 57:1-10
29. Christen Y (2004) Ginkgo biloba and neurodegenerative disorders. Front Biosci 9:3091-3104
30. Christen Y (2010) Does Ginkgo biloba extract exert an effect on Alzheimer's disease progression? [Chap. 17]. In: Micronutrients and brain health. Taylor & Francis, Boca Raton, FL, USA, Oxid Stress Dis 26:243-254
31. Cohen-Salmon C, Venault P, Martin B, Raffalli-Sébille MJ, Barkats M, Clostre F, Pardon MC, Christen Y, Chapouthier G (1997) Effects of Ginkgo biloba extract (EGb 761®) on learning and possible actions on aging. J Physiol Paris 91:291-300
32. Colciaghi F, Borroni B, Zimmermann M, Bellone C, Longhi A, Padovani A, Cattabeni F, Christen Y, Di Luca M (2004) Amyloid precursor protein metabolism is regulated toward alphasecretase pathway by Ginkgo biloba extracts. Neurobiol Dis 16:454-460
33. Continella G, Drago F (1984) Behavioral effect of Ginkgo biloba extract. In: Agnoli A, Rapin JR, Scapagnini V, Weitbrecht WV (eds) Effects of Ginkgo biloba-extract on organic cerebral impairment. John Libbey, London, pp 35-42
34. De Feudis FV (2003) Ginkgo biloba extract, from chemistry to the clinic. Urban & Fischer
35. Munich De Kosky ST, Williamson J, Fitzpatrick A, Kronmal RA, Ives DG, Saxton J, Lopez O, Burke G, Carlson M, Fried L, Kuller LH, Robbins J, Tracy RP, Woolard NF, Dunn L, Snitz BE, Nahin RL, Furberg CD, for the GEM Study Investigators (2008) Ginkgo biloba for primary prevention of dementia: results of the Ginkgo evaluation of memory (GEM) study. JAMA 300:2253-2262
36. De Marchi U, Campello S, Szabò I, Tombola F, Martinou JC, Zoratti M (2004) Bax does not directly participate in the Ca (2+)-induced permeability transition of isolated mitochondira. J Biol Chem 279:37415-22
37. Dorman DC, Cote LM, Buck WB (1992) Effects of an extract of Ginkgo biloba on bromethalininduced cerebral lipid peroxidation and edema in rats. Am J Vet Res 53:138-142
38. Dumont E, Petit E, Tarrade T, Nouvelot A (1992) UV-C irradiation-induced peroxidative degradation of microsomal fatty acids and proteins: protection by an extract of Ginkgo biloba (EGb 761®). Free Radic Biol Med 13:197-203
39. Eckert A, Keil U, Scherping I, Hauptmann S, Mueller WE (2005) Stabilization of mitochondrial membrane potential and improvement of neuronal energy metabolism by Ginkgo biloba extract EGb 761®. Ann N Y Acad Sci 1056:474-485
40. EMEA/CHMP/SWP/431994 (2007) Guideline on the limits of genotoxic impurities
41. Emerit I, Arutyunyan R, Oganesian N, Levy A, Cernjavsky L, Sarkisian T, Pogossian A, Asrian K (1995) Radiation-induced clastogenic factors: anticlastogenic effect of Ginkgo biloba extract. Free Radic Biol Med 18:985-991
42. Erdinçler DS, Karakoç Y, Toplan S, Önen S, Sukyasyan A, Beg'er T, Demirog'lu Ç (1996) The effect of Ginkgo biloba glycoside on the blood viscosity and erythrocyte deformability. Clin Hemorheol 16:271-276
43. ESCOP (2003) Ginkgo biloba, Euro. Sci. Cooperative Phytother. (ESCOP). Thieme, Stuttgart
44. Fehske CJ, Leuner K, Müller WE (2009) Ginkgo biloba extract (EGb 761®) influences monoaminergic neurotransmission via inhibition of NE uptake, but not MAO activity after chronic treatment. Pharmacol Res 60:68-73
45. Fitzl G, Welt K, Martin R, Dettmer D, Hermsdorf T, Clemens N, Konig S (2000) The influence of hypoxia on the myocardium of experimentally diabetic rats with and without protection by Ginkgo biloba extract. I. Ultrastructural and biochemical investigations on cardiomyocytes. Exp Toxicol Pathol 52:419-30
46. Fourtillan JB, Brisson AM, Girault J, Ingrand I, Decourt JP, Drieu K, Jouenne P, Biber A (1995) Proprietes pharmacocinetiques du Bilobalide et des Ginkgolides A et B chez le sujet sain apres administrations intraveneuses et orals d'extrait de Ginkgo biloba (EGb-761®) [Pharmacokinetics of bilobalide, Ginkgolide A and Ginkgolide B in healthy volunteers following oral and intravenous administrations of Ginkgo biloba extract (EGb 761®)]. Therapie 50(2):137-144
47. Fransen HP (2010) Assessment of health claims, content, and safety of herbal supplements containing Ginkgo biloba. Food Nutr Res 54:5221
48. Garcia-Alloza M, Dodwell SA, Meyer-Luehmann M, Hyman BT, Bacskai BJ (2006) Plaquederived oxidative stress mediates distorted neurite trajectories in the Alzheimer mouse model. J Neuropathol Exp Neurol 65:1082-9
49. Gawron-Gzella A, Marek P, Chanay J, Matlawska I (2010) Comparative analysis of aharmaceuticals and dietary supplements containing extracts from the leaves of Ginkgo biloba L. Acta Pol Pharm 67(4):335-43
50. Grass-Kapanke B, Busmane A, Lasmanis A, Hoerr R, Kaschel R (2011) Effects of Ginkgo biloba special extract EGb 761® in very mild cognitive impairment (vMCI). Neurosci Med 2:48-56
51. Halama P, Bartsch G, Meng G (1988) Cerebrovascular insufficiency - placebo-controlled, randomised, doubleblind trial on the effect of Ginkgo biloba extract (in German). Fortschr Med 106:408-412
52. Hamann KF (2007) Ginkgo special extract EGb 761® in vertigo: a systematic review of randomised, double-blind, placebo-controlled clinical trials. Internet J Otorhinolaryngol 6 (2) HeissWD, Zeiler K (1978) Medikamentöse Beeinflussung der Hirndurchblutung. Pharmakotherapie 1:137-144
53. Herrschaft H, Nacu A, Likhachev S, Sholomov I, Hoerr R, Schlaefke S, on behalf of the GOT-IT! Study Group (2012) Ginkgo biloba extract EGb 761 (R) in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg. J Psychiatr Res 46:716-723
54. Hofferberth B (1989) Effect of Ginkgo biloba extract on neurophysiological and psychometric measurement results in patients with cerebro-organic syndrome - a double-blind study versus placebo (in German). Arzneimittelforschung 39:918-922
55. Hofferberth B (1991) Simultanerfassung elektrophysiologischer, psychometrischer und rheologischer Parameter bei Patienten mit hirnorganischem Psychosyndrom und erhöhtem Gefäßrisiko - Eine placebokontrollierte Doppelblindstudie mit Ginkgo-biloba-Extrakt EGb 761®. In: Stodtmeister R, Pillunat LE (eds) Mikrozirkulation in Gehirn und Sinnesorganen. Enke, Stuttgart, pp 64-74
56. Horsch S, Walther C (2004) Ginkgo biloba special extract EGb 761® in the treatment of peripheral arterial occlusive disease (PAOD) - a review based on randomized, controlled studies. Int J Clin Pharmacol Ther 42:63-72
57. Hoyer S, Lannert H, Noeldner M, Chatterjee SS (1999) Damaged neuronal energy metabolism and behavior are improved by Ginkgo biloba extract (EGb 761®). J Neural Transm 106:1171-1188
58. Hsu CL, Wu YL, Tang GJ, Lee TS, Kou YR (2009) Ginkgo biloba extract confers protection from cigarette smoke extract-induced apoptosis in human lung endothelial cells: role of heme oxygenase-1. Pulm Pharmacol Ther 22:286-296
59. Huang SH, Duke RK, Chebib M, Sasaki K, Wada K, Johnston GA (2003) Bilobalide, a sesquiterpene trilactone from Ginkgo biloba, is an antagonist at recombinant alpha1beta2gamma2L GABA (A) receptors. Eur J Pharmacol 464:1-8
60. Huguet F, Tarrade T (1992) Alpha2-adrenoceptor changes during cerebral ageing: the effect of Ginkgo biloba extract. J Pharm Pharmacol 44:24-27
61. Huguet F, Drieu K, Piriou A (1994) Decreased cerebral 5-HT1A receptors during ageing: reversal by Ginkgo biloba extract EGb 761®). J Pharm Pharmacol 46:316-318
62. Ihl R, Bachinskaya N, Korczyn AD, Vakhapova V, Tribanek M, Hoerr R, Napryeyenko O, on behalf of the GOTADAY Study Group (2011) Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features - a randomized controlled trial. Int J Geriatr Psychiatry 26:1186-1194
63. IQWiG Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (2008) Ginkgohaltige Präparate bei Alzheimer Demenz - Abschlussbericht A05-19B.
64. Iqwi G, Köln Israël L, Dell'Accio E, Martin G, Hugonot R (1987) Ginkgo biloba extract and memory training programs - comparative assessment on elderly outpatients living in the community (in French). Psychol Med (Paris) 19:1431-1439
65. Ivic L, Sands TT, Fishkin N, Nakanishi K, Kriegstein AR, Strømgaard K (2003) Terpene trilactones from Ginkgo biloba are antagonists of cortical glycine and GABA (A) receptors. J Biol Chem 278:49279-85
66. Jack CR, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ (2010) Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 9:119-128
67. Jaggy H, Koch E (1997) Chemistry and biology of alkylphenols from Ginkgo biloba L. Pharmazie 52(10):735-738
68. Janssens D, Michiels C, Delaive E, Eliaers F, Drieu K, Remacle J (1995) Protection of hypoxiainduced ATP decrease in endothelial cells by Ginkgo biloba extract and Bilobalide. Biochem Pharmacol 50:991-999
69. Janssens D, Remacle J, Drieu K, Michiels C (1999) Protection of mitochondrial respiration activity by Bilobalide. Biochem Pharmacol 58:109-119
70. Janssens D, Delaive E, Remacle J, Michiels C (2000) Protection by bilobalide of the ischaemiainduced alterations of the mitochondrial respiratory activity. Fundam Clin Pharmacol 14:193-201
71. Jessen F, Wiese B, Bachmann C, Eifflaender-Gorfer S, Haller F, Kölsch H, Luck T, Mösch E, Van Den Bussche H, Wagner M, Wollny A, Zimmermann T, Pentzek M, Riedel-Heller SG, Romberg HP, Weyerer S, Kaduszkiewicz H, Maier W, Bickel H, for the German Study on Aging, Cognition and Dementia in Primary Care Patients Study Group (2010) Prediction of dementia by subjective memory impairment. Arch Gen Psychiatry 67:414-422
72. Kampkötter A, Pielarski T, Rohrig R, Timpel C, Chovolou Y, Wätjen W, Kahl R (2007) The Ginkgo biloba extract EGb 761® reduces stress sensitivity, ROS accumulation and expression of catalase and glutathione S-transferase 4 in Caenorhabditis elegans. Pharmacol Res 55:139-47
73. Kanowski S, Herrmann WM, Stephan K, Wierich W, Hörr R (1996) Proof of efficacy of the Ginkgo biloba special extract EGb 761® in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. Pharmacopsychiatry 29:47-56
74. Karcher L, Zagrmann P, Krieglstein J (1984) Effect of an extract of Ginkgo biloba on rat brain energy metabolism in hypoxia. Naunyn-Schmiedeberg's Arch Pharmacol 327:31-35
75. Kaschel R, Hörr R, Kresimon J, Rychlik R (2007) Einfluss von Ginkgo-Spezialextrakt EGb 761® auf die Leistungsfähigkeit bei gesunden Probanden am Bildschirmarbeitsplatz - Offene klinische Studie im Prä-Post-Design mit Kontrollgruppe. Perfusion 16:3-9
76. Kasper S, Schubert H (2009) Ginkgo biloba extract EGb 761® in the treatment of dementia: evidence of efficacy and tolerability (in German). Fortschr Neurol Psychiatr 77:494-506
77. Keles MS, Demirci N, Yildirim A, Atamanalp SS, Altinkaynak K (2008) Protective effects of N-acetylcysteine and Ginkgo biloba extract on ischaemia-reperfusion-induced hepatic DNA damage in rats. Clin Exp Med 8:193-8
78. Kellermann AJ, Kloft C (2011) Is there a risk of bleeding associated with standardized Ginkgo biloba extract therapy? A systematic review and meta-analysis. Pharmacotherapy 31:490-502
79. Klein J, Chatterjee SS, Loeffelholz K (1995) Hypoxia-induced release of choline from rat brain: potent inhibition by bilobalide. Biol Chem Hoppe-Seyler 376(Suppl):S116
80. Klein J, Chatterjee SS, Loeffelholz K (1997) Phospholipid breakdown and choline release under hypoxic conditions: inhibition by bilobalide, a constituent of Ginkgo biloba. Brain Res 755:347-350
81. Klein J, Weichel O, Hilgert M, Rupp J, Chatterjee SS, Nawrath H (2003) Excitotoxic hippocampal membrane breakdown and its inhibition by bilobalide: role of chloride fluxes. Pharmacopsychiatry 36(Suppl 1):78-83
82. Koch E (2005) Inhibition of platelet activating factor (PAF)-induced aggregation of human thrombocytes by ginkgolides: considerations on possible bleeding complications after oral intake of Ginkgo biloba extracts. Phytomedicine 12:10-16
83. Koch E, Chatterjee SS (1993) Experimentelle Grundlagen fuer die therapeutische Anwendung von Ginkgoextrakt EGb 761® bei der Behandlung vaskulaerer Erkrankungen. Haemostaseologie 13:11-27
84. Koh PO (2009) Ginkgo biloba extract (EGb 761®) prevents increase of Bad-Bcl-X (L) interaction following cerebral ischemia. Am J Chin Med 37:867-876
85. Koltermann A (2007) Influence of Ginkgo biloba extract EGb 761® on signaling pathways in endothelial cells. Dissertation, Pharm Biol Pharm, Ludwig-Maximilians-Universitaet, Muenchen DE. p 155
86. Költringer P, Langsteger W, Eber O (1995) Dose-dependent hemorheological effects and microcirulatory modifications following intravenous administration of Ginkgo biloba special extract EGb 761®. Clin Hemorheol 15:649-656
87. Krieglstein J, Beck T, Seibert A (1986) Influence of an extract of Ginkgo biloba on cerebral blood flow and metabolism. Life Sci 39:2327-34
88. Krieglstein J, Ausmeier F, El-Abhar H, Lippert K, Welsch M, Rupalla K, Henrich-Noack P (1995) Neuroprotective effects of Ginkgo biloba constituents. Eur J Pharm Sci 3:39-48
89. Kristofikova Z, Benesova O, Tejkalova H (1992) Changes of high-affinity choline uptake in the hippocampus of old rats after long-term administration of two nootropic drugs (Tacrine and Ginkgo biloba extract). Dementia 3:304-307
90. Krzywon M, Tawab M, Schubert-Zsilavecz M (2008) Ginkgohaltige Teeprodukte nicht ohne Risiko. Pharm Ztg 153(13):4474-4479
91. Le Bars PL, Katz MM, Berman N, Itil TM, Freedman AM, Schatzberg AF, for the North American EGb Study Group (1997) A placebo-controlled, double-blind randomized trial of an extract of Ginkgo biloba for dementia. JAMA 278:1327-1332
92. Le Poncin-Lafitte M, Rapin J, Rapin JR (1980) Effects of Ginkgo Biloba on changes induced by quantitative cerebral microembolization in rats. Arch Int Pharmacodyn Ther 243:236-44
93. Leistner E, Drewke C (2010a) Ginkgo biloba and ginkgotoxin. J Nat Prod 73:86-92
94. Leistner E, Drewke C (2010b) Arznei- und Nahrungsmittel aus Ginkgo biloba Potenziell toxische Inhaltsstoffe und ihre Wirkmechanismen [Drug and nutrition aspects of Ginkgo biloba] Dtsch. Apoth Ztg 150(17):1930-1935
95. Lin FY, Chen YH, Chen YL, Wu TC, Li CY, Chen JW, Lin SJ (2007) Ginkgo biloba extract inhibits endotoxin-induced human aortic smooth muscle cell proliferation via suppression of toll-like receptor 4 expression and NADPH oxidase activation. J Agric Food Chem 55:1977-1984
96. Liu KX, Wu WK, He W, Liu CL (2007) Ginkgo biloba extract (EGb 761®) attenuates lung injury induced by intestinal ischemia/reperfusion in rats: roles of oxidative stress and nitric oxide. World J Gastroenterol 14:299-305
97. Longpre F, Garneau P, Christen Y, Ramassamy C (2006) Protection by EGb 761® against betaamyloidinduced neurotoxicity: involvement of NF-kappa B, SIRT1, and MAPKs pathways and inhibition of amyloid fibril formation. Free Radic Biol Med 41:1781-1794
98. Luo Y, Smith JV, Paramasivam V, Burdick A, Curry KJ, Buford JP, Khan I, Netzer WJ, Xu H, Butko P (2002) Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761. Proc Natl Acad Sci USA 99:12197-202
99. Mahadevan S, Park Y (2008) Multifaceted therapeutic benefits of Ginkgo biloba L.: chemistry, efficacy, safety, and uses. J Food Sci 73:R14-R19
100. Martin R, Mozet C, Martin H, Welt K, Engel C, Fitzl G. (2010) Effect of Ginkgo biloba extract (EGb 761®) on parameters of oxidative stress in different regions of aging rat brain after acute hypoxia. Aging Clin. Exp. Res. [Epub ahead of print], DOI:10.3275/7229
101. Meier B, Hasler A, Sticher O (1992) HPLC analyses of the main Ginkgo acylflavonol glycosides. Planta Med 58(Suppl 7):A688-A689
102. Meyer B (1986) A mulitcentre, randomized, double-blind drug versus placebo study of Ginkgo biloba extract in the treatment of tinnitus (in French). Presse Med 15:1562-1564
103. Mizuno M, Droy-Lefaix MT, Packer L (1996) Ginkgo biloba extract EGb 761® is a suppressor of AP-1 transcription factor stimulated by phorbol 12-myristate 13-acetate. Biochem Mol Biol Int 39:395-401
104. Moeller CK, Kurt S, Scheich H, Schulze H (2009) Improvement of auditory discrimination learning by Ginkgo biloba extract EGb 761® (R). Neurosci Lett 463:219-222
105. Moreau P (1975) Un nouveau stimulant circulatoire cérébral. Nouv Presse Med 4:2401-2402
106. Moreau J-P, Bommelaer G, Buscail L, Benque A, Jacob CO, Galleyrand J, Ribet (1986) A preliminary results of a multicentric double blind trial of somatostatin [s] vs placebo [p] in akute pancreatitis [ap] [Abstr. 85], 8th Congr. Gastroenterol. (OMGE), 6th Congr. Dig. Endosc. (OMED), 3rd. Congr. Colo-Proctol., Sao Paolo BR, 7.-12. 9. 1986, Dig Dis Sci 31 (10, Suppl.)
107. Morgenstern C, Biermann E (1997) Ginkgo special extract (EGb 761®) in the treatment of tinnitus aurium - results of a randomized, double-blind, placebo-controlled study (in German). Fortschr Med Orig 115:7-11
108. Morgenstern C, Biermann E (2002) The efficacy of Ginkgo special extract EGb 761® in patients with tinnitus. Int J Clin Pharmacol Ther 40:188-197
109. Müller WE, Abdel-Kader RM, Fehske CJ, Leuner K (2009) Grundlagen der therapeutischen Anwendung von EGb 761® (R). Wirkung auf die Kraftwerke der Zellen. Pharm Unserer Zeit 38:408-416
110. Mußgnug G, Alemany J (1968) Studies on disorders of peripheral arterial circulation. Part XV: problems of conservative therapy of obliterating disorders of peripheral circulation demonstrated on tincture and extract of Ginkgo biloba (in German). Arzneimittelforschung 18:453-550
111. Myers S (2007) The complexities of botanical quality, natural products insider, http://www.naturalproductsinsider.com. Accessed 05 July 2011, Article not accessible)
112. Napryeyenko O, Borzenko I, for the GINDEM-NP Study Group (2007) Ginkgo biloba special extract in dementia with neuropsychiatric features - a randomized, placebo-controlled, doubleblind clinical trial. Arzneimittelforschung 57:4-11
113. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (2001) Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 357:169-175
114. Niizuma K, Yoshioka H, Chen H, Kim GS, Jung JE, Katsu M, Okami N, Chan PH (2010) Mitochondrial and apoptotic neuronal death signaling pathways in cerebral ischemia. Biochim Biophys Acta 1802:92-9
115. Noeldner M, Chatterjee SS (1994) Anxiolytic-like activity of bilobalide [Abstr. 388]. Naunyn Schmiedeberg's Arch Pharmacol 349(Suppl):R97
116. Oberpichler-Schwenk H, Beck T, Abdel-Rahman MM, Bielenberg GW, Krieglstein J (1988) Effects of Ginkgo biloba constituents related to protection against brain damage caused by hypoxia. Pharmacol Res Commun 20:349-368
117. Otani M, Chatterjee SS, Gabard BL, Kreutzberg GW (1986) Effect of an extract of Ginkgo biloba on Triethyltin-induced cerebral edema. Acta Neuropathol 69:54-65
118. Pardon MC, Joubert C, Perez-Diaz F, Christen Y, Launay JM, Cohen-Salmon C (2000) In vivo regulation of cerebral monoamine oxidase activity in senescent controls and chronically stressed mice by long-term treatment with Ginkgo biloba extract (EGb 761®). Mech Ageing Dev 113:157-68
119. Peter H, Fisel J, Weisser W (1966) Zur Pharmakologie der Wirkstoffe aus Ginkgo biloba. Arzneimittelforschung 16:719-25
120. Pietta PG, Gardana C, Mauri PL, Maffei FR, Carini M (1995) Identification of flavonoid metabolites after oral administration to rats of a Ginkgo biloba extract. J Chromatogr B Biomed Appl 673(1):75-80
121. Pincemail J, Deby C (1986) The antiradical properties of Ginkgo biloba extract. Presse Med 15(31):1475-1479
122. Porsolt RD, Martin P, Lenegre A, Fromage S, Drieu K (1990) Effects of an extract of Ginkgo biloba (EGb 761® [TANAKAN]) on "learned helplessness" and other models of stress in rodents. Pharmacol Biochem Behav 36:963-971
123. Rangel-Ordóñez L, Noeldner M, Schubert-Zsilavecz M, Wurglics M (2010) Plasma levels and distribution of flavonoids in rat brain after single and repeated doses of standardized Ginkgo biloba extract EGb 761® (R). Planta Med 76(15):1683-1690
124. Rickard NS, Kowadlo N, Gibbs ME (2001) Effect of the Ginkgo biloba extract, EGb 761®, on memory formation in day-old chicks. Pharmacol Biochem Behav 69:351-358
125. Rimbach G, Cermak R, Wolffram S (2004) Gene regulatory activity of Ginkgo biloba L. (Chap. 5). In: Bao Y, Fenwick R (eds) Phytochemicals in health and disease. Marcel Dekker, New York, pp 105-119
126. Rojas P, Rojas-Castañeda J, Vigueras RM, Rojas C (2000) Ginkgo biloba pretreatment partially protects from the dopaminergic neurotoxicity of 1-methyl-4-phenylpyridinium. Proc West Pharmacol Soc 43:87-8
127. Rojas P, Garduño B, Rojas C, Vigueras RM, Rojas-Castañeda J, Rios C, Serrano-Garcia N (2001) EGb761 blocks MPP+-induced lipid peroxidation in mouse corpus striatum. Neurochem Res 26:1245-51
128. Rojas P, Serrano-García N, Mares-Sámano JJ, Medina-Campos ON, Pedraza-Chaverri J, Ogren SO (2008) EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress. Eur J Neurosci 28:41-50
129. Sakakibara H, Ishida K, Grundmann O, Nakajima JI, Seo S, Butterweck V, Minami Y, Saito S, Kawai Y, Nakaya Y, Terao J (2006) Antidepressant effect of extracts from Ginkgo biloba leaves in behavioral models. Biol Pharm Bull 29:1767-1770
130. Saleem S, Zhuang H, Biswal S, Christen Y, Dore S (2008) Ginkgo Biloba extract neuroprotective action is dependent on heme oxygenase 1 in ischemic reperfusion brain injury. Stroke 39:3389-3396
131. Sanceario G, Kreutzberg GW (1986) Stimulation of astrocytes affects cytotoxic brain edema. Acta Neuropathol 72:3-14
132. Saponaro A, Gambelli G, Cosentino F (1971) First results from a clinical and instrumental investigation of the effects of a new phytotherapeutic substance on the cerebral and peripheral arterial circulation (in Italian). Minerva Med 62:4838-4849
133. Schennen A (1988) Neue Inhaltsstoffe aus den Blaettern von Ginkgo biloba. 1. sowie Praeparation 14c-markierter Ginkgo-flavonoidepharm Biol. Dissertation, Univ. Marburg
134. Schindowski K, Leutner S, Kressmann S, Eckert A, Mueller WE (2001) Age-related increase of oxidative stress-induced apoptosis in mice: prevention by Ginkgo biloba extract (EGb 761®). J Neural Transm 108:969-978
135. Schneider LS, De Kosky ST, Farlow MR, Tariot PN, Hoerr R, Kieser M (2005) A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type. Curr Alzheimer Res 2:541-551
136. Schneider JA, Arvanitakis Z, Bang W, Bennett DA (2007) Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 69:2197-2204
137. Scholtyssek H, Damerau W, Wessel R, Schimke I (1997) Antioxidative activity of ginkgolides against superoxide in an aprotic environment. Chem Biol Interact 106:183-190
138. Schötz K (2002) Detection of allergenic urushiols in Ginkgo biloba leaves. Pharmazie 57(7):508-510
139. Shah ZA, Nada SE, Doré S (2011) Heme oxygenase 1, beneficial role in permanent ischemic stroke and in Gingko biloba (EGb 761®) neuroprotection. Neuroscience 180:248-255
140. Shen J, Lee W, Gu Y, Tong Y, Fung PC, Tong L (2011) Ginkgo biloba extract EGb 761®) inhibits mitochondria-dependent caspase pathway and prevents apoptosis in hypoxia-reoxygenated cardiomyocytes. Chin Med 6:8
141. Shi C, Wu F, Yew DT, Xu J, Zhu Y (2010) Bilobalide prevents apoptosis through activation of the PI3K/Akt pathway in SH-SY5Y cells. Apoptosis 15:715-727
142. Smith JV, Burdick AJ, Golik P, Khan I, Wallace D, Luo Y (2002) Anti-apoptotic properties of Ginkgo biloba extract EGb 761® in differentiated PC12 cells. Cell Mol Biol 48:699-707
143. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR (1997) Brain infarction and the clinical expression of Alzheimer disease - The Nun Study. JAMA 277:813-817
144. Soulie C, Nicole A, Christen Y, Ceballos-Picot I (2002) The Ginkgo biloba extract EGb 761® increases viability of hnt human neurons in culture and affects the expression of genes implicated in the stress response. Cell Mol Biol 48:641-646
145. Spiess E, Juretzek W (2004) Hagers Handbuch der Pharmazeutischen Praxis, CD-Ausg. Hager ROM, Springer, Berlin, Heidelberg Ginkgo biloba, HN 2032700
146. Sram RJ, Binkova B (1993) Side-effects of psychotropic therapy. In: Packer L, Prilipko L, Christen Y (eds) Free radicals in the brain - aging, neurological and mental disorders; Joint Meeting World Health Organization (WHO), Found. IPSEN. Springer, Berlin, pp 153-166
147. Stackman RW, Eckenstein F, Frei B, Kulhanek D, Nowlin J, Quinn JF (2003) Prevention of agerelated spatial memory deficits in a transgenic mouse model of Alzheimer's disease by chronic Ginkgo biloba treatment. Exp Neurol 184:510-20
148. Sticher O (1992) Ginkgo biloba - Analytik und Zubereitungsformen. Pharm Unserer Zeit 21(6):253-265
149. Stoll S, Scheuer K, Pohl O, Mueller WE (1996) Ginkgo biloba extract (EGb-761) independently improves changes in passive avoidance learning and brain membrane fluidity in the aging mouse. Pharmacopsychiatry 29:144-149
150. Su SY, Hsieh CL, Wu SL, Cheng WY, Li CC, Lo HY, Ho TY, Hsiang CY (2009) Transcriptomic analysis of EGb 761®-regulated neuroactive receptor pathway in vivo. J Ethnopharmacol 123:68-73
151. Taillandier J, Ammar A, Rabourdin JP, Ribeyre JP, Pichon J, Niddam S, Pierart H (1986) Ginkgo biloba extract in the treatment of cerebral disorders due to ageing - a longitudinal, multicentric, double-blind, drug versus placebo trial (in French). Presse Med 15:1583-1587
152. Tawab M, Krzywon M, Schubert-Zsilavecz M (2010) Nahrungsergänzungs-mittel mit Ginkgo unter der Lupe. Pharm Ztg 155(20):1994-1999
153. Tchantchou F, Xu Y, Wu Y, Christen Y, Luo Y (2007) EGb 761® enhances adult hippocampal neurogenesis and phosphorylation of CREB in transgenic mouse model of Alzheimer's disease. FASEB J 21:2400-2408
154. Tendi EA, Bosetti F, Dasgupta SF, Stella AM, Drieu K, Rapoport SI (2002) Ginkgo biloba extracts EGb 761® and bilobalide increase NADH dehydrogenase mRNA level and mitochondrial respiratory control ratio in PC12 cells. Neurochem Res 27:319-323
155. Ude C, Paulke A, Noeldner M, Schubert-Zsilavecz M, Wurglics M (2011) Plasma and brain levels of terpene trilactones in rats after an oral single dose of standardized Ginkgo biloba extract EGb 761® (R). Planta Med 77(3):259-264
156. Upton R, (2003) Ginkgo leaf Ginkgo leaf dry extract Ginkog biloba L: standards of analysis, quality control and therapeutics. American Herbal Pharmacopoeia and Therapeutic Compendium, Santa Cruz, CA, USA
157. Uríková A, Babusíková E, Dobrota D, Drgová A, Kaplán P, Tatarková Z, Lehotský J (2006) Impact of Ginkgo biloba Extract EGb 761® on ischemia/reperfusion-induced oxidative stress products formation in rat forebrain. Cell Mol Neurobiol 26:1343-53
158. Van Beek TA (ed) (2000) Ginkgo biloba. Harwood Academic Publishers, Amsterdam
159. Van Beek TA, Montoro P (2009) Chemical analysis and Quality control of Ginkgo biloba leaves, extracts and phytopharmaceuticals. J Chromatogr A 1216(11):2002-2032
160. Vellas B, Coley N, Ousset PJ, Berrut G, Dartigues JF, Dubois B, Grandjean H, Pasquier F, Piette F, Robert P, Touchon J, Garnier P, Mathiex-Fortunet H, Andrieu S, for the GuidAge Study Group (2010) Results of GuidAge - a 5-year placebo-controlled study of the efficacy of EGb 761® 120 mg to prevent or delay Alzheimer's dementia onset in elderly subjects with memory complaint. J Nutr Health Aging 14(Suppl 2):S23
161. Walesiuk A, Trofimiuk E, Braszko JJ (2005) Gingko biloba extract diminishes stress-induced memory deficits in rats. Pharmacol Rep 57:176-87
162. Watanabe CMH, Wolffram S, Ader P, Rimbach G, Packer L, Maguire JJ, Schultz PG, Gohil K (2001) The in vivo neuromodulatory effects of the herbal medicine Ginkgo biloba. Proc Natl Acad Sci USA 98:6577-6580
163. Wang BS, Wang H, Song YY, Qi H, Rong ZX, Wang BS, Zhang L, Chen HZ (2010) Effectiveness of standardized Ginkgo biloba extract on cognitive symptoms of dementia with a six-month treqatment: a bivariate random effect meta-analysis. Pharmacopsychiatry 43:86-91
164. Weichel O, Hilgert M, Chatterjee SS, Lehr M, Klein J (1999) Bilobalide, a constituent of Ginkgo biloba, inhibits NMDA-induced phospholipase A2 activation and phospholipid breakdown in rat hippocampus. Naunyn Schmiedebergs Arch Pharmacol 360:609-15
165. Weinmann S, Roll S, Schwarzbach C (2010) Effects of Ginkgo biloba in dementia: systematic review and meta-analysis. BMC Geriatr 10 (14)
166. Weitbrecht WU, Jansen W (1986) Ginkgo biloba extract in the treatment of primary degenerative dementia - placebo-controlled, double-blind and comparative study (in German). Fortschr Med 104:199-202
167. Wesnes K, Simmons D, Rook M, Simpson P (1987) A double-blind placebo-controlled trial of Tanakan in the treatment of idiopathic cognitive impairment in the elderly. Hum Psychopharmacol 2:159-169
168. Wilson RS, Leurgans SE, Boyle PA, Schneider JA, Bennett DA (2010) Neurodegenerative basis of age-related cognitive decline. Neurology 75:1070-1078
169. Winter E (1991) Effects of an extract of Ginkgo biloba on learning and memory in mice. Pharmacol Biochem Behav 38:109-14
170. Winter JC (1998) The effects of an extract of Ginkgo biloba, EGb 761®, on cognitive behavior and longevity in the rat. Physiol Behav 63:425-33
171. Wirth S, Stemmelin J, Will B, Christen Y, Di Scala G (2000) Facilitative effects of EGb 761® on olfactory recognition in young and aged rats. Pharmacol Biochem Behav 65:321-6
172. Wu Y, Wu Z, Butko P, Christen Y, Lambert MP, Klein WL, Link CD, Luo Y (2006) Amyloidbetainduced pathological behaviors are suppressed by Ginkgo biloba extract EGb 761® and ginkgolides in transgenic Caenorhabditis elegans. J Neurosci 26:13102-13113
173. Yan FL, Zheng Y, Zhao FD (2008) Effects of Ginkgo biloba extract EGb-761 on expression of RAGE and LRP-1 in cerebral microvascular endothelial cells under chronic hypoxia and hypoglycemia. Acta Neuropathol 116:529-535
174. Yeh YC, Liu TJ, Wang LC, Lee HW, Ting CT, Lee WL, Hung CJ, Wang KY, Lai HC, Lai HC (2009) A standardized extract of Ginkgo biloba suppresses doxorubicin-induced oxidative stress and p53-mediated mitochondrial apoptosis in rat testes. Br J Pharmacol 156:48-61
175. Yoshitake T, Yoshitake S, Kehr J (2010) The Ginkgo biloba extract EGb 761® and its main constituent flavonoids and ginkgolides increase extracellular dopamine levels in the rat prefrontal cortex. Br J Pharmacol 159:659-68
176. Zhuang H, Pin S, Christen Y, Dore S (2002) Induction of heme oxygenase 1 by Ginkgo biloba in neuronal cultures and potential implications in ischemia. Cell Mol Biol 48:647-653
177. Zou W, Kim BO, Zhou BY, Liu Y, Messing A, He JJ (2007) Protection against human immunodeficiency virus type 1 Tat neurotoxicity by Ginkgo biloba extract EGb 761® involving glial fibrillary acidic protein. Am J Pathol 171:1923-35